Alfuzosin + Dutasteride Tablets

Alfuzosin + Dutasteride Tablets

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 10 mg + 0.5 mg

Alfuzosin + Dutasteride Tablets are a combination therapy designed for the effective management of benign prostatic hyperplasia (BPH) in men. This dual-action formulation combines an alpha-1 adrenergic blocker (Alfuzosin) with a 5-alpha reductase inhibitor (Dutasteride) to provide both immediate symptomatic relief and long-term prostate size reduction.

Alfuzosin helps relax the smooth muscles of the prostate and bladder neck, improving urine flow, while Dutasteride works by reducing dihydrotestosterone (DHT) levels, thereby shrinking the enlarged prostate over time.

Genliva Wellness LLP is a trusted Alfuzosin + Dutasteride Tablets manufacturer in India, offering premium-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a growing Alfuzosin Dutasteride Tablets exporter and contract manufacturer, the company ensures global-quality standards, consistent efficacy, and regulatory compliance.

With strong expertise in pharmaceutical contract manufacturing, third-party production, and global export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, catering to urology specialists, hospitals, and international distributors.

Send Message

Alfuzosin + Dutasteride Tablets are a combination therapy designed for the effective management of benign prostatic hyperplasia (BPH) in men. This dual-action formulation combines an alpha-1 adrenergic blocker (Alfuzosin) with a 5-alpha reductase inhibitor (Dutasteride) to provide both immediate symptomatic relief and long-term prostate size reduction.

Alfuzosin helps relax the smooth muscles of the prostate and bladder neck, improving urine flow, while Dutasteride works by reducing dihydrotestosterone (DHT) levels, thereby shrinking the enlarged prostate over time.

Genliva Wellness LLP is a trusted Alfuzosin + Dutasteride Tablets manufacturer in India, offering premium-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a growing Alfuzosin Dutasteride Tablets exporter and contract manufacturer, the company ensures global-quality standards, consistent efficacy, and regulatory compliance.

With strong expertise in pharmaceutical contract manufacturing, third-party production, and global export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, catering to urology specialists, hospitals, and international distributors.

  • Leading Alfuzosin + Dutasteride Tablets manufacturer in India with GMP certification
  • Reliable Alfuzosin Dutasteride Tablets exporter for global pharmaceutical markets
  • Specialized Alfuzosin Dutasteride Tablets contract manufacturer for third-party production
  • Dual-action formulation for symptom relief and prostate size reduction
  • High-quality APIs ensuring enhanced therapeutic effectiveness
  • Available in standard combinations such as Alfuzosin 10 mg + Dutasteride 0.5 mg
  • Manufactured under strict quality control and international regulatory standards
  • Suitable for bulk supply, institutional procurement, and long-term therapy markets
  • Offered with custom packaging, private labeling, and branding solutions
  • Export-ready with complete documentation (COA, MSDS, stability data)
  • Backed by Genliva’s expertise as a global pharmaceutical exporter from India

Alfuzosin + Dutasteride Tablets are widely used in urology for:

  • Treatment of benign prostatic hyperplasia (BPH)
  • Improvement of urinary flow and reduction of urinary obstruction
  • Management of lower urinary tract symptoms (LUTS) such as:
    • Frequent urination
    • Weak urine stream
    • Nocturia (night-time urination)
  • Reduction of prostate size over time
  • Prevention of acute urinary retention (AUR)
  • Lowering the need for surgical intervention in prostate enlargement
  • Oral tablet ensures convenient once-daily administration
  • Combination therapy improves patient compliance and treatment outcomes
  • Provides both short-term relief and long-term disease management
  • Stable formulation suitable for global export and long shelf life
  • Cost-effective solution for chronic urology treatment markets
  • Available in blister packs and bulk packaging for international distribution
  • Ideal for private label brands and pharmaceutical distributors

whatsapp-app